Who's buying Psyence Biomedical Ltd.?

PBM insider buying, 13F and 13D filings

• Oct 15, 202613D stake (no activist plan)
  Psyence Labs Ltd.: Amended Schedule 13D: 49.8% stake
  Item 4 of the Original Schedule 13D is hereby amended and restated in its entirety as follows: The Reporting Person acquired the Subject Shares pursuant to the exercise of an irrevocable put option granted to the Reporting Person under the Put Option Agreement, as previously disc…
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.